DE69233507D1 - Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten - Google Patents

Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten

Info

Publication number
DE69233507D1
DE69233507D1 DE69233507T DE69233507T DE69233507D1 DE 69233507 D1 DE69233507 D1 DE 69233507D1 DE 69233507 T DE69233507 T DE 69233507T DE 69233507 T DE69233507 T DE 69233507T DE 69233507 D1 DE69233507 D1 DE 69233507D1
Authority
DE
Germany
Prior art keywords
treatment
polypeptides
hbgad
higad
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233507T
Other languages
English (en)
Other versions
DE69233507T2 (de
Inventor
Leonard Harrison
Margo Honeyman
David Cram
Aizpurua Henry De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of DE69233507D1 publication Critical patent/DE69233507D1/de
Application granted granted Critical
Publication of DE69233507T2 publication Critical patent/DE69233507T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69233507T 1991-02-22 1992-02-21 Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten Expired - Fee Related DE69233507T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPK477391 1991-02-22
AU477391 1991-02-22
AU862091 1991-09-27
AUPK862091 1991-09-27
PCT/AU1992/000063 WO1992014485A1 (en) 1991-02-22 1992-02-21 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases

Publications (2)

Publication Number Publication Date
DE69233507D1 true DE69233507D1 (de) 2005-06-16
DE69233507T2 DE69233507T2 (de) 2009-09-10

Family

ID=25644008

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233507T Expired - Fee Related DE69233507T2 (de) 1991-02-22 1992-02-21 Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten

Country Status (9)

Country Link
US (2) US5837812A (de)
EP (1) EP0572478B1 (de)
JP (1) JP3027190B2 (de)
AT (1) ATE304050T1 (de)
AU (1) AU659133B2 (de)
CA (1) CA2104225C (de)
DE (1) DE69233507T2 (de)
DK (1) DK0572478T3 (de)
WO (1) WO1992014485A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
JPH06508030A (ja) * 1991-05-15 1994-09-14 ザイモジェネティクス，インコーポレイティド ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現
AU661684B2 (en) * 1991-06-18 1995-08-03 Regents Of The University Of California, The Cloned glutamic acid decarboxylase
DE4237244A1 (de) * 1992-11-04 1994-05-05 Elias Entwicklungslabor Fuer I Verfahren zur Herstellung hochreiner humaner GAD-1- und GAD-2- Proteine
IL108587A (en) * 1993-02-09 1998-01-04 Univ Monash Methods and kit for diagnosing diabetes and pre-diabetic conditions
AU688304B2 (en) * 1993-02-09 1998-03-12 Monash University Methods for the diagnosis of diabetes and prediabetic conditions
EP0815136B1 (de) 1995-02-20 2007-06-13 The Walter And Eliza Hall Institute Of Medical Research Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
WO1997010847A1 (en) * 1995-09-21 1997-03-27 University Of Utah Research Foundation Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
WO1997036618A1 (fr) * 1996-04-01 1997-10-09 Chugai Seiyaku Kabushiki Kaisha Composition diagnostique pour maladies s'accompagnant de reactions auto-immunes declenchees par la decarboxylase d'acide 65k-glutamique
US7361331B2 (en) 1996-10-18 2008-04-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Plant bioreactors
AU2001242190A1 (en) * 2000-03-31 2001-10-15 Aventis Pasteur Limited Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
CA2448112A1 (en) * 2001-06-05 2002-12-12 Exelixis Inc. Lces as modifiers of the p53 pathway and methods of use
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
US7485314B2 (en) * 2002-05-06 2009-02-03 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Induction of antigen specific immunologic tolerance
US20050191309A1 (en) * 2002-05-06 2005-09-01 Kakkis Emil D. Induction of antigen specific immunologic tolerance
EP1893754A4 (de) * 2005-05-31 2009-01-21 Neurologix Inc Neue glutaminsäure-decarboxylase (gad)-chimäre und verwendungsverfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE144326T1 (de) * 1990-08-17 1996-11-15 Univ Florida Verfahren und komposition zum frühnachweiss und behandlung insulinabhängiger diabetes
AU8721991A (en) * 1990-09-07 1992-03-30 Regents Of The University Of California, The Methods for the diagnosis and treatment of diabetes
US5475086A (en) * 1990-09-21 1995-12-12 The Regents Of The University Of California Cloned glutamic acid decarboxylase peptides
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase

Also Published As

Publication number Publication date
JPH06505385A (ja) 1994-06-23
EP0572478B1 (de) 2005-09-07
CA2104225A1 (en) 1992-08-23
DK0572478T3 (da) 2006-01-16
JP3027190B2 (ja) 2000-03-27
AU659133B2 (en) 1995-05-11
US6211352B1 (en) 2001-04-03
DE69233507T2 (de) 2009-09-10
US5837812A (en) 1998-11-17
CA2104225C (en) 2001-07-17
ATE304050T1 (de) 2005-09-15
AU1274892A (en) 1992-09-15
EP0572478A4 (en) 1994-05-18
WO1992014485A1 (en) 1992-09-03
EP0572478A1 (de) 1993-12-08

Similar Documents

Publication Publication Date Title
DE69233507D1 (de) Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten
Fujii et al. Homochirality and life
UA39161C2 (uk) Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
PT939804E (pt) Neutroquina alfa
ATE438657T1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
ATE168135T1 (de) Diagnose von retinoblastoma
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
EP0192175A3 (de) Polypeptide des Rhinovirusstammes HRV2 sowie die hierfür codierenden DNA-Moleküle
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
Bichsel et al. Requirements for the quality control of chemically synthesized peptides and biotechnologically produced proteins
HUP0001057A2 (hu) A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
DE69431874D1 (de) Verfahren zur diagnose von diabetes und praediabetischer bedingungen
DE60024862D1 (de) "insulinabhängiges sequenz dna bindendes protein-1" (irsdbp-1), dafür kodierendes gen und ihre verwendungen
Sanger Les Prix Nobel en
Weber The role of amino acid residues 1-45 in the binding of prothrombin to phospholipid membranes.
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도
ATE276755T1 (de) Verwendung eines fibroblastenwachstumsfaktor- bindeproteins zur behandlung und diagnose von diabetischen wundheilugnsstörungen

Legal Events

Date Code Title Description
8372 Publication of ep patent withdrawn
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: ADVOTEC. PATENT- UND RECHTSANWAELTE, 57234 WILNSDO

8339 Ceased/non-payment of the annual fee